TABLE 2.
Strain designation | DTDB utilization | Susceptibilitya | Source or reference |
---|---|---|---|
Rhodococcus erythropolis MI2 | + | Cm, Ts | This study; reference 17 |
Rhodococcus erythropolis PR4 | + | Cm, Ts | This study |
Rhodococcus erythropolis IGTS8 | + | Cm, Ts | This study |
Rhodococcus ruber | + | Cm, Ts, Km, Ap | This study |
Rhodococcus erythropolis ATCC 4277T | − | Ap, Cm, Gm, Km, Tc, Ts | This study |
Rhodococcus jostii RHA1 | − | Cm, Ts, Km, Ap | This study |
Rhodococcus opacus R7 | − | Cm, Ts, Km, Ap | This study |
Rhodococcus sp. strain BCP1 | − | Cm, Ts, Km, Ap | This study |
Rhodococcus erythropolis SQ1 | − | Cm, Ts, Km, Ap | This study |
Rhodococcus erythropolis BEA1 | − | Ap, Cm, Gm, Km, Pn, Sm, Tc, Ts | 17 |
Rhodococcus erythropolis BEA2 | − | Ap, Cm, Gm, Km, Pn, Sm, Tc, Ts | 17 |
Rhodococcus erythropolis BEA3 | − | Ap, Cm, Gm, Pn, Sm, Tc, Ts | 17 |
Rhodococcus erythropolis BEA4 | − | Ap, Cm, Gm, Km, Pn, Sm, Tc, Ts | 17 |
Ap, ampicillin; Cm, chloramphenicol; Gm, gentamicin; Km, kanamycin; Pn, penicillin; Sm, streptomycin; Tc, tetracycline, Ts, thiostrepton.